ADMA Biologics (ADMA) Reaches $2.96 1 Year Low; Legal & General Group Plc Has Raised Its Healthstream (HSTM) Stake

June 22, 2017 - By Marie Mckinney

Legal & General Group Plc increased Healthstream Inc (HSTM) stake by 104.64% reported in 2016Q4 SEC filing. Legal & General Group Plc acquired 21,681 shares as Healthstream Inc (HSTM)’s stock rose 23.08%. The Legal & General Group Plc holds 42,401 shares with $1.06 million value, up from 20,720 last quarter. Healthstream Inc now has $956.76 million valuation. The stock rose 1.42% or $0.42 reaching $30.09 per share. About 28,584 shares traded. HealthStream, Inc. (NASDAQ:HSTM) has risen 29.68% since June 22, 2016 and is uptrending. It has outperformed by 12.98% the S&P500.

The stock of ADMA Biologics Inc (NASDAQ:ADMA) hit a new 52-week low and has $2.78 target or 6.00% below today’s $2.96 share price. The 9 months bearish chart indicates high risk for the $38.65 million company. The 1-year low was reported on Jun, 22 by Barchart.com. If the $2.78 price target is reached, the company will be worth $2.32M less. The stock decreased 2.31% or $0.07 on June 22, reaching $2.96. About 94,446 shares traded or 155.63% up from the average. ADMA Biologics Inc (NASDAQ:ADMA) has declined 37.56% since June 22, 2016 and is downtrending. It has underperformed by 54.26% the S&P500.

Among 8 analysts covering Healthstream (NASDAQ:HSTM), 4 have Buy rating, 1 Sell and 3 Hold. Therefore 50% are positive. Healthstream had 10 analyst reports since July 22, 2015 according to SRatingsIntel. The company was initiated on Tuesday, March 29 by FBR Capital. The company was downgraded on Wednesday, July 27 by First Analysis. The company was initiated on Monday, August 3 by Raymond James. The stock of HealthStream, Inc. (NASDAQ:HSTM) earned “Hold” rating by Needham on Wednesday, July 22. The firm earned “Outperform” rating on Wednesday, June 29 by Barrington Research. The stock has “Strong-Buy” rating by Zacks on Tuesday, August 4. The firm earned “Underweight” rating on Monday, January 23 by First Analysis. Robert W. Baird upgraded HealthStream, Inc. (NASDAQ:HSTM) on Friday, December 2 to “Outperform” rating. The rating was initiated by Sidoti with “Neutral” on Wednesday, December 30.

Legal & General Group Plc decreased Chimera Invt Corp stake by 31,624 shares to 139,205 valued at $2.37 million in 2016Q4. It also reduced Regency Ctrs Corp (NYSE:REG) stake by 5,892 shares and now owns 646,078 shares. Rogers Communications Inc (NYSE:RCI) was reduced too.

Investors sentiment increased to 1.79 in 2016 Q4. Its up 0.16, from 1.63 in 2016Q3. It increased, as 9 investors sold HSTM shares while 29 reduced holdings. 12 funds opened positions while 56 raised stakes. 23.85 million shares or 3.20% more from 23.11 million shares in 2016Q3 were reported. Teachers Retirement Systems Of The State Of Kentucky has 6,300 shares. Da Davidson And holds 5,466 shares or 0% of its portfolio. Huntington Comml Bank invested in 0% or 2,434 shares. Panagora Asset Mngmt Incorporated owns 43,634 shares. New Jersey-based Blackrock Mngmt Ltd Liability Com has invested 0% in HealthStream, Inc. (NASDAQ:HSTM). 69,595 are owned by Wall Street. Stephens Inv Mngmt Group Ltd Liability accumulated 0.39% or 552,460 shares. Arrowpoint Asset Mgmt Lc accumulated 262,414 shares. Cap Impact Advisors Ltd Llc invested in 43,814 shares. 184,455 were reported by Bank & Trust Of America De. State Board Of Administration Of Florida Retirement System reported 16,444 shares. The United Kingdom-based Blackrock Grp Limited has invested 0% in HealthStream, Inc. (NASDAQ:HSTM). Great West Life Assurance Can has 34,304 shares for 0% of their portfolio. Pinebridge Invests Lp reported 0% stake. Pembroke Mgmt Limited holds 1.05 million shares.

Investors sentiment decreased to 0.57 in 2016 Q4. Its down 0.18, from 0.75 in 2016Q3. It fall, as 0 investors sold ADMA Biologics Inc shares while 7 reduced holdings. 0 funds opened positions while 4 raised stakes. 7.94 million shares or 1.17% less from 8.03 million shares in 2016Q3 were reported. Tower Rech Ltd Co (Trc) has invested 0% in ADMA Biologics Inc (NASDAQ:ADMA). Prelude Capital Ltd Com owns 30,000 shares. Consonance Capital Mgmt Lp holds 0.72% of its portfolio in ADMA Biologics Inc (NASDAQ:ADMA) for 1.27M shares. State Bank Of America De holds 1 shares. Vanguard Group Inc Inc reported 145,394 shares. 1.11M were accumulated by Broadfin Cap Ltd Co. Geode Capital Management Limited Liability Co holds 0% of its portfolio in ADMA Biologics Inc (NASDAQ:ADMA) for 23,282 shares. Blackrock Invest Llc holds 856 shares. Morgan Stanley accumulated 0% or 8,237 shares. Spark Investment Mngmt Ltd Liability Co invested in 0.01% or 13,380 shares. Weiss Multi invested 0.02% of its portfolio in ADMA Biologics Inc (NASDAQ:ADMA). Aisling Ltd Liability Corp stated it has 4.29% of its portfolio in ADMA Biologics Inc (NASDAQ:ADMA). Fmr has 0% invested in ADMA Biologics Inc (NASDAQ:ADMA). Blackrock Fund invested in 0% or 18,213 shares. 721,102 were accumulated by Perceptive Advsr Ltd.

Among 2 analysts covering ADMA Biologics (NASDAQ:ADMA), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. ADMA Biologics has $15 highest and $13 lowest target. $14’s average target is 372.97% above currents $2.96 stock price. ADMA Biologics had 5 analyst reports since September 9, 2015 according to SRatingsIntel. The firm has “Buy” rating by Maxim Group given on Thursday, September 17. The company was downgraded on Monday, August 1 by Maxim Group. The company was upgraded on Monday, January 23 by Maxim Group. The rating was downgraded by Raymond James to “Market Perform” on Monday, August 1. The company was initiated on Wednesday, September 9 by Raymond James.